510(k) · Cleared
Recalled · 2009Cell-Dyn 1600 Multiparameter Auto. Hema. Analyzer
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Abbott Diagnostics · GKZ Counter, Differential Cell
Cleared on Mar 17, 1987 after a 55-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 4 later devices descend from it. It has been recalled 5 times.
- Decided
- Mar 17, 1987
- Review
- 55 days
- Class
- Class II
- Product code
- GKZ
- Recalls
- 5
- Predicates
- 0
4 later devices descend from it, 2 citing it directly.
- This deviceK870233 Cell-Dyn 1600 Multiparameter Auto. Hema. AnalyzerAbbott Diagnostics · 1987
- Descendant · cites it directly · 2 of its ownK030513 Cell-Dyn 1800 SystemAbbott Laboratories · 2003 · Recalled
- Descendant · 2 generations on · 0 of its ownK111534 Abacus 3CPDiatron U.S., Inc. · 2012 · Recalled
- Descendant · 2 generations on · 0 of its ownK081495 Cell-Dyn Emerald SystemAbbott Laboratories · 2009 · Recalled
- Descendant · cites it directly · 0 of its ownK991142 Cell-Dyn 1200 SystemAbbott Laboratories · 1999 · Recalled
Most influential descendants
Showing 4 of 4 · See all- K030513Cell-Dyn 1800 SystemAbbott Laboratories · 2003 · cites it directly2descendants
- K111534Abacus 3CPDiatron U.S., Inc. · 2012 · 2 generations on0descendants
- K081495Cell-Dyn Emerald SystemAbbott Laboratories · 2009 · 2 generations on0descendants
- K991142Cell-Dyn 1200 SystemAbbott Laboratories · 1999 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K870233 | Cell-Dyn 1600 Multiparameter Auto. Hema. Analyzer | Abbott Diagnostics | 1987 | — |
| +1 | K030513 | Cell-Dyn 1800 System | Abbott Laboratories | 2003 | 3 |
| +2 | K111534 | Abacus 3CP | Diatron U.S., Inc. | 2012 | 2 |
| +2 | K081495 | Cell-Dyn Emerald System | Abbott Laboratories | 2009 | 7 |
| +1 | K991142 | Cell-Dyn 1200 System | Abbott Laboratories | 1999 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 1 | 0 |
| 2003 | 1 | 0 |
| 2009 | 1 | 0 |
| 2012 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GKZ device
- #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA has not posted a summary or statement for it, so its predicates are not known.
What descends from it? (4)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Nov 30, 2009 | Not classified | Z-1698-2011 | Other | The use of the device assemblies has been extended to a 6 month useful life. |
| Jun 8, 2009 | Not classified | Z-1629-2010 | Nonconforming Material/Component | Use of Syringe LN 04H36-01 with the Die-cast syringe drive may result in leakage, leading to delay in reporting patient results. |
| Jun 8, 2009 | Not classified | Z-1628-2010 | Nonconforming Material/Component | Use of Syringe LN 04H36-01 with the Die-cast syringe drive may result in leakage, leading to delay in reporting patient results. |
| May 16, 2007 | Not classified | Z-1170-2007 | Other | Abnormal results may not be "flagged" appropriately because of a software anomaly. (Flags for the Hemoglobin (HGB), MCH and MCHC parameters when the upper assay paramter limit has been exceeded) |
| May 16, 2007 | Not classified | Z-1171-2007 | Other | Abnormal results may not be "flagged" appropriately because of a software anomaly. (Flags for the Hemoglobin (HGB), MCH and MCHC parameters when the upper assay paramter limit has been exceeded) |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K030513 (Abbott Laboratories, 2003) has gone furthest, with 2 descendants of its own.
How does its category compare?
All GKZ devicesGKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GKZ
4in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GKZ
108in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GKZ
1in 2025
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · GKZ
77in 2025
MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 117 | 37 | 268 |
| 2008 | 6 | 99 | 5 | 925 |
| 2009 | 6 | 147 | 13 | 559 |
| 2010 | 4 | 290 | 27 | 896 |
| 2011 | 3 | 315 | 28 | 2,905 |
| 2012 | 3 | 408 | 7 | 2,959 |
| 2013 | 1 | — | 6 | 3,070 |
| 2014 | 3 | 165 | 0 | 3,112 |
| 2015 | 3 | 273 | 3 | 1,972 |
| 2016 | 3 | 198 | 3 | 3,338 |
| 2017 | 4 | 280 | 3 | 229 |
| 2018 | 3 | 270 | 2 (2) | 497 |
| 2019 | 5 | 210 | 2 | 908 |
| 2020 | 1 | — | 1 | 342 |
| 2021 | 0 | — | 0 | 391 |
| 2022 | 3 | 638 | 4 | 198 |
| 2023 | 4 | 329 | 1 | 155 |
| 2024 | 3 | 157 | 0 | 115 |
| 2025 | 4 | 108 | 1 | 77 |
| 2026 | 4 | 254 | 0 | — |
https://510kreport.com/device/K870233 · printed Nov 6, 2026
Cite this page
510(k) Report. “K870233: Cell-Dyn 1600 Multiparameter Auto. Hema. Analyzer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K870233
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026